0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 0.9% Sodium Chloride Intravenous Infusion Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-1J12515
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global 0 9 Sodium Chloride Intravenous Infusion Market Research Report 2022
BUY CHAPTERS

Global 0.9% Sodium Chloride Intravenous Infusion Market Research Report 2025

Code: QYRE-Auto-1J12515
Report
February 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

0.9% Sodium Chloride Intravenous Infusion Market Size

The global market for 0.9% Sodium Chloride Intravenous Infusion was valued at US$ 1320 million in the year 2024 and is projected to reach a revised size of US$ 1652 million by 2031, growing at a CAGR of 3.3% during the forecast period.

0.9% Sodium Chloride Intravenous Infusion Market

0.9% Sodium Chloride Intravenous Infusion Market

0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic.
The sodium chloride injection bag market is primarily driven by its essential role in intravenous (IV) fluid therapy, making it a critical medical device in healthcare settings. These bags contain sterile saline solution, used for hydration, electrolyte balance, and dilution of medications, indispensable in various medical procedures, surgeries, and emergency care. The increasing prevalence of conditions requiring IV fluid administration, such as dehydration, infections, and trauma, fuels the demand for sodium chloride injection bags. However, the market also faces challenges, including the rising concerns about plastic waste and environmental impact associated with single-use medical devices like IV bags. Manufacturers are actively exploring sustainable packaging options and eco-friendly materials to address these environmental challenges. Additionally, supply chain disruptions and fluctuations in the availability and cost of raw materials can impact the production and distribution of sodium chloride injection bags, posing challenges for healthcare facilities in ensuring a stable supply for patient care.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 0.9% Sodium Chloride Intravenous Infusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 0.9% Sodium Chloride Intravenous Infusion.
The 0.9% Sodium Chloride Intravenous Infusion market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 0.9% Sodium Chloride Intravenous Infusion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 0.9% Sodium Chloride Intravenous Infusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of 0.9% Sodium Chloride Intravenous Infusion Market Report

Report Metric Details
Report Name 0.9% Sodium Chloride Intravenous Infusion Market
Accounted market size in year US$ 1320 million
Forecasted market size in 2031 US$ 1652 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Kelun Group, Baxter, Fresenius Kabi, Shijiazhuang No.4 Pharmaceutical, CR Double-Crane, B.Braun, Otsuka, Cisen Pharmaceutical, Hospira (ICU Medical), Huaren Pharmaceuticals, Zhejiang Chimin, Dubang Pharmaceutical, Guizhou Tiandi, Qidu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of 0.9% Sodium Chloride Intravenous Infusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of 0.9% Sodium Chloride Intravenous Infusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is 0.9% Sodium Chloride Intravenous Infusion Market growing?

Ans: The 0.9% Sodium Chloride Intravenous Infusion Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the 0.9% Sodium Chloride Intravenous Infusion Market size in 2031?

Ans: The 0.9% Sodium Chloride Intravenous Infusion Market size in 2031 will be US$ 1652 million.

Who are the main players in the 0.9% Sodium Chloride Intravenous Infusion Market report?

Ans: The main players in the 0.9% Sodium Chloride Intravenous Infusion Market are Kelun Group, Baxter, Fresenius Kabi, Shijiazhuang No.4 Pharmaceutical, CR Double-Crane, B.Braun, Otsuka, Cisen Pharmaceutical, Hospira (ICU Medical), Huaren Pharmaceuticals, Zhejiang Chimin, Dubang Pharmaceutical, Guizhou Tiandi, Qidu Pharmaceutical

What are the Application segmentation covered in the 0.9% Sodium Chloride Intravenous Infusion Market report?

Ans: The Applications covered in the 0.9% Sodium Chloride Intravenous Infusion Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the 0.9% Sodium Chloride Intravenous Infusion Market report?

Ans: The Types covered in the 0.9% Sodium Chloride Intravenous Infusion Market report are Flexible Bag, Plastic Bottles, Glass Bottle

Recommended Reports

Intravenous Saline Solutions

Infusion & IV Bags

Pharmaceutical Sodium Chloride

1 0.9% Sodium Chloride Intravenous Infusion Market Overview
1.1 Product Definition
1.2 0.9% Sodium Chloride Intravenous Infusion by Type
1.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Type (2024 VS 2031)
1.2.2 Flexible Bag
1.2.3 Plastic Bottles
1.2.4 Glass Bottle
1.3 0.9% Sodium Chloride Intravenous Infusion by Application
1.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global 0.9% Sodium Chloride Intravenous Infusion Market Size Estimates and Forecasts
1.4.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue 2020-2031
1.4.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales 2020-2031
1.4.3 Global 0.9% Sodium Chloride Intravenous Infusion Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 0.9% Sodium Chloride Intravenous Infusion Market Competition by Manufacturers
2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Manufacturers (2020-2025)
2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 0.9% Sodium Chloride Intravenous Infusion Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 0.9% Sodium Chloride Intravenous Infusion, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Product Type & Application
2.7 Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Date of Enter into This Industry
2.8 Global 0.9% Sodium Chloride Intravenous Infusion Market Competitive Situation and Trends
2.8.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 0.9% Sodium Chloride Intravenous Infusion Players Market Share by Revenue
2.8.3 Global 0.9% Sodium Chloride Intravenous Infusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 0.9% Sodium Chloride Intravenous Infusion Market Scenario by Region
3.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2020-2031
3.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2020-2025
3.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2026-2031
3.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2020-2031
3.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2020-2025
3.3.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2026-2031
3.4 North America 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.4.1 North America 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2020-2031)
3.4.3 North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.5.1 Europe 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2020-2031)
3.5.3 Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Region
3.6.1 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2020-2031)
3.6.3 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.7.1 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2020-2031)
3.7.3 Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.8.1 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2020-2031)
3.8.3 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2020-2031)
4.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2020-2025)
4.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2026-2031)
4.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Type (2020-2031)
4.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2020-2031)
4.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2020-2025)
4.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2026-2031)
4.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Type (2020-2031)
4.3 Global 0.9% Sodium Chloride Intravenous Infusion Price by Type (2020-2031)
5 Segment by Application
5.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2020-2031)
5.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2020-2025)
5.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2026-2031)
5.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Application (2020-2031)
5.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2020-2031)
5.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2020-2025)
5.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2026-2031)
5.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Application (2020-2031)
5.3 Global 0.9% Sodium Chloride Intravenous Infusion Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Kelun Group
6.1.1 Kelun Group Company Information
6.1.2 Kelun Group Description and Business Overview
6.1.3 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.1.5 Kelun Group Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Company Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Shijiazhuang No.4 Pharmaceutical
6.4.1 Shijiazhuang No.4 Pharmaceutical Company Information
6.4.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
6.4.3 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.4.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
6.5 CR Double-Crane
6.5.1 CR Double-Crane Company Information
6.5.2 CR Double-Crane Description and Business Overview
6.5.3 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.5.5 CR Double-Crane Recent Developments/Updates
6.6 B.Braun
6.6.1 B.Braun Company Information
6.6.2 B.Braun Description and Business Overview
6.6.3 B.Braun 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.6.4 B.Braun 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.6.5 B.Braun Recent Developments/Updates
6.7 Otsuka
6.7.1 Otsuka Company Information
6.7.2 Otsuka Description and Business Overview
6.7.3 Otsuka 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Otsuka 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Cisen Pharmaceutical
6.8.1 Cisen Pharmaceutical Company Information
6.8.2 Cisen Pharmaceutical Description and Business Overview
6.8.3 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.8.5 Cisen Pharmaceutical Recent Developments/Updates
6.9 Hospira (ICU Medical)
6.9.1 Hospira (ICU Medical) Company Information
6.9.2 Hospira (ICU Medical) Description and Business Overview
6.9.3 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.9.5 Hospira (ICU Medical) Recent Developments/Updates
6.10 Huaren Pharmaceuticals
6.10.1 Huaren Pharmaceuticals Company Information
6.10.2 Huaren Pharmaceuticals Description and Business Overview
6.10.3 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.10.5 Huaren Pharmaceuticals Recent Developments/Updates
6.11 Zhejiang Chimin
6.11.1 Zhejiang Chimin Company Information
6.11.2 Zhejiang Chimin Description and Business Overview
6.11.3 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.11.5 Zhejiang Chimin Recent Developments/Updates
6.12 Dubang Pharmaceutical
6.12.1 Dubang Pharmaceutical Company Information
6.12.2 Dubang Pharmaceutical Description and Business Overview
6.12.3 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.12.5 Dubang Pharmaceutical Recent Developments/Updates
6.13 Guizhou Tiandi
6.13.1 Guizhou Tiandi Company Information
6.13.2 Guizhou Tiandi Description and Business Overview
6.13.3 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.13.5 Guizhou Tiandi Recent Developments/Updates
6.14 Qidu Pharmaceutical
6.14.1 Qidu Pharmaceutical Company Information
6.14.2 Qidu Pharmaceutical Description and Business Overview
6.14.3 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.14.5 Qidu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 0.9% Sodium Chloride Intravenous Infusion Industry Chain Analysis
7.2 0.9% Sodium Chloride Intravenous Infusion Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 0.9% Sodium Chloride Intravenous Infusion Production Mode & Process Analysis
7.4 0.9% Sodium Chloride Intravenous Infusion Sales and Marketing
7.4.1 0.9% Sodium Chloride Intravenous Infusion Sales Channels
7.4.2 0.9% Sodium Chloride Intravenous Infusion Distributors
7.5 0.9% Sodium Chloride Intravenous Infusion Customer Analysis
8 0.9% Sodium Chloride Intravenous Infusion Market Dynamics
8.1 0.9% Sodium Chloride Intravenous Infusion Industry Trends
8.2 0.9% Sodium Chloride Intravenous Infusion Market Drivers
8.3 0.9% Sodium Chloride Intravenous Infusion Market Challenges
8.4 0.9% Sodium Chloride Intravenous Infusion Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global 0.9% Sodium Chloride Intravenous Infusion Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global 0.9% Sodium Chloride Intravenous Infusion Market Competitive Situation by Manufacturers in 2024
 Table 4. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) of Key Manufacturers (2020-2025)
 Table 5. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market 0.9% Sodium Chloride Intravenous Infusion Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of 0.9% Sodium Chloride Intravenous Infusion, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Product Type & Application
 Table 12. Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global 0.9% Sodium Chloride Intravenous Infusion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 0.9% Sodium Chloride Intravenous Infusion as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global 0.9% Sodium Chloride Intravenous Infusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2020-2025) & (K Unit)
 Table 18. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Region (2020-2025)
 Table 19. Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2026-2031) & (K Unit)
 Table 20. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Region (2026-2031)
 Table 21. Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Region (2020-2025)
 Table 23. Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Region (2026-2031)
 Table 25. North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2020-2025) & (K Unit)
 Table 27. North America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2026-2031) & (K Unit)
 Table 28. North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2020-2025) & (K Unit)
 Table 32. Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2026-2031) & (K Unit)
 Table 33. Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2020-2025) & (K Unit)
 Table 37. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2026-2031) & (K Unit)
 Table 38. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2020-2025) & (K Unit)
 Table 42. Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2026-2031) & (K Unit)
 Table 43. Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2020-2025) & (K Unit)
 Table 47. Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2026-2031) & (K Unit)
 Table 48. Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) by Type (2020-2025)
 Table 51. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) by Type (2026-2031)
 Table 52. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Type (2020-2025)
 Table 53. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Type (2026-2031)
 Table 54. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Type (2020-2025)
 Table 57. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Type (2026-2031)
 Table 58. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Type (2020-2025)
 Table 59. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Type (2026-2031)
 Table 60. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) by Application (2020-2025)
 Table 61. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) by Application (2026-2031)
 Table 62. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Application (2020-2025)
 Table 63. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Application (2026-2031)
 Table 64. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Application (2020-2025)
 Table 67. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Application (2026-2031)
 Table 68. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Application (2020-2025)
 Table 69. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Application (2026-2031)
 Table 70. Kelun Group Company Information
 Table 71. Kelun Group Description and Business Overview
 Table 72. Kelun Group 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Kelun Group 0.9% Sodium Chloride Intravenous Infusion Product
 Table 74. Kelun Group Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Baxter 0.9% Sodium Chloride Intravenous Infusion Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. Fresenius Kabi Company Information
 Table 81. Fresenius Kabi Description and Business Overview
 Table 82. Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Product
 Table 84. Fresenius Kabi Recent Developments/Updates
 Table 85. Shijiazhuang No.4 Pharmaceutical Company Information
 Table 86. Shijiazhuang No.4 Pharmaceutical Description and Business Overview
 Table 87. Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product
 Table 89. Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
 Table 90. CR Double-Crane Company Information
 Table 91. CR Double-Crane Description and Business Overview
 Table 92. CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Product
 Table 94. CR Double-Crane Recent Developments/Updates
 Table 95. B.Braun Company Information
 Table 96. B.Braun Description and Business Overview
 Table 97. B.Braun 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. B.Braun 0.9% Sodium Chloride Intravenous Infusion Product
 Table 99. B.Braun Recent Developments/Updates
 Table 100. Otsuka Company Information
 Table 101. Otsuka Description and Business Overview
 Table 102. Otsuka 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Otsuka 0.9% Sodium Chloride Intravenous Infusion Product
 Table 104. Otsuka Recent Developments/Updates
 Table 105. Cisen Pharmaceutical Company Information
 Table 106. Cisen Pharmaceutical Description and Business Overview
 Table 107. Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product
 Table 109. Cisen Pharmaceutical Recent Developments/Updates
 Table 110. Hospira (ICU Medical) Company Information
 Table 111. Hospira (ICU Medical) Description and Business Overview
 Table 112. Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Product
 Table 114. Hospira (ICU Medical) Recent Developments/Updates
 Table 115. Huaren Pharmaceuticals Company Information
 Table 116. Huaren Pharmaceuticals Description and Business Overview
 Table 117. Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Product
 Table 119. Huaren Pharmaceuticals Recent Developments/Updates
 Table 120. Zhejiang Chimin Company Information
 Table 121. Zhejiang Chimin Description and Business Overview
 Table 122. Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Product
 Table 124. Zhejiang Chimin Recent Developments/Updates
 Table 125. Dubang Pharmaceutical Company Information
 Table 126. Dubang Pharmaceutical Description and Business Overview
 Table 127. Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product
 Table 129. Dubang Pharmaceutical Recent Developments/Updates
 Table 130. Guizhou Tiandi Company Information
 Table 131. Guizhou Tiandi Description and Business Overview
 Table 132. Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Product
 Table 134. Guizhou Tiandi Recent Developments/Updates
 Table 135. Qidu Pharmaceutical Company Information
 Table 136. Qidu Pharmaceutical Description and Business Overview
 Table 137. Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product
 Table 139. Qidu Pharmaceutical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. 0.9% Sodium Chloride Intravenous Infusion Distributors List
 Table 143. 0.9% Sodium Chloride Intravenous Infusion Customers List
 Table 144. 0.9% Sodium Chloride Intravenous Infusion Market Trends
 Table 145. 0.9% Sodium Chloride Intravenous Infusion Market Drivers
 Table 146. 0.9% Sodium Chloride Intravenous Infusion Market Challenges
 Table 147. 0.9% Sodium Chloride Intravenous Infusion Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of 0.9% Sodium Chloride Intravenous Infusion
 Figure 2. Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global 0.9% Sodium Chloride Intravenous Infusion Market Share by Type: 2024 & 2031
 Figure 4. Flexible Bag Product Picture
 Figure 5. Plastic Bottles Product Picture
 Figure 6. Glass Bottle Product Picture
 Figure 7. Global 0.9% Sodium Chloride Intravenous Infusion Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global 0.9% Sodium Chloride Intravenous Infusion Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Other
 Figure 12. Global 0.9% Sodium Chloride Intravenous Infusion Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global 0.9% Sodium Chloride Intravenous Infusion Market Size (2020-2031) & (US$ Million)
 Figure 14. Global 0.9% Sodium Chloride Intravenous Infusion Sales (2020-2031) & (K Unit)
 Figure 15. Global 0.9% Sodium Chloride Intravenous Infusion Average Price (US$/Unit) & (2020-2031)
 Figure 16. 0.9% Sodium Chloride Intravenous Infusion Report Years Considered
 Figure 17. 0.9% Sodium Chloride Intravenous Infusion Sales Share by Manufacturers in 2024
 Figure 18. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest 0.9% Sodium Chloride Intravenous Infusion Players: Market Share by Revenue in 0.9% Sodium Chloride Intravenous Infusion in 2024
 Figure 20. 0.9% Sodium Chloride Intravenous Infusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global 0.9% Sodium Chloride Intravenous Infusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Country (2020-2031)
 Figure 23. North America 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Country (2020-2031)
 Figure 24. United States 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Country (2020-2031)
 Figure 27. Europe 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Country (2020-2031)
 Figure 28. Germany 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Region (2020-2031)
 Figure 35. China 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Country (2020-2031)
 Figure 43. Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of 0.9% Sodium Chloride Intravenous Infusion by Type (2020-2031)
 Figure 53. Global Revenue Market Share of 0.9% Sodium Chloride Intravenous Infusion by Type (2020-2031)
 Figure 54. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of 0.9% Sodium Chloride Intravenous Infusion by Application (2020-2031)
 Figure 56. Global Revenue Market Share of 0.9% Sodium Chloride Intravenous Infusion by Application (2020-2031)
 Figure 57. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Application (2020-2031)
 Figure 58. 0.9% Sodium Chloride Intravenous Infusion Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart